More reads
- Biotech has a supply problem. (Wall Street Journal)
- Buttigieg’s balancing act: He wants far lower drug prices even as he hopes the drug industry will ‘thrive.’ (STAT Plus)
- New biotech aims to develop a reversible form of gene editing. (Boston Business Journal)
- Beyond the Sacklers: Free-trade policies contributed to the opioid epidemic. (STAT)
No hay comentarios:
Publicar un comentario